AMETEK AME
AMETEK scores good on business quality (6.7 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What AMETEK does
AMETEK manufactures electronic instruments and electromechanical devices across two primary operating segments, selling specialized hardware to industrial and aerospace customers.
- What it does best
AMETEK dominates high-end niche electronic instruments with an operating margin of 26.5%, significantly outperforming peer VRT at 19.4%. This edge stems from proprietary technology and specialized applications that make customer switching costs prohibitive.
- The main risk
Valuation stands at a steep 36.6 P/E with an intrinsic value of $154.09 against a $251.93 price, exposing investors to severe multiple compression if industrial demand softens.
Quality, check by check
Scored against its own industry, from company filings.
Operating margin sits at 26.5% and free cash flow margin hits the 95th sector percentile, expanding as high-value niche scale increases.
Proprietary electronic instruments lock in specialized industrial and aerospace customers, supported by an operating margin ranking in the 93rd sector percentile.
Revenue grew 6.6% to $7.9B, continuing a steady multi-year expansion visible across annual summaries.
Debt-to-equity is manageable at 0.2, and interest coverage of 24.1x makes debt costs minor. Free cash flow reached $1.8B, getting stronger.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
1 insider bought $1.0M on the open market. 1 sold $1.7M outside pre-planned sales.
Our sealed record on AME
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
AMETEK scores good on the Cluenex quality check (6.7 of 10), measured against its own industry. Profitability is strong, moat fair, growth steady and financial health strong.
In the last 90 days of SEC Form 4 filings: 1 insider bought $1.0M on the open market. 1 sold $1.7M outside pre-planned sales.
Nov 3, 2026, before the open.
See AME today
- Today's verdict on AME, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “AMETEK (AME)”, https://cluenex.com/stocks/ame/, data as of Oct 10, 2026.